CurrentRheuma
Get Weekly

Topic · page 12 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 441–480 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

  1. Arthritis Rheumatol

    Podocyte Interleukin‐23 Receptor Signaling in the Pathogenesis of Lupus Nephritis

    Mechanistic study

  2. Clin Exp Rheumatol

    CD163+ macrophage infiltration reflects disease activity and early treatment response in lupus nephritis

    Cohort study

  3. Arthritis Care Res (Hoboken)

    Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically Active

    Cohort study

  4. Arthritis Rheumatol

    Reactive Oxygen Species–Induced Modifications of Fibrin Clots as a Link Between Immune Responses and Atherothrombosis in Systemic Lupus Erythematosus

    Cross-sectional study

  5. Lupus

    Effect of hydroxychloroquine dose reduction (2–3 mg/kg/day) on lipoprotein levels in stable lupus nephritis: A 12-month randomized controlled longitudinal study

    Randomized controlled trial

  6. Arthritis Res Ther

    Differential complement pathways and components in the clinical spectrum of systemic lupus erythematosus

    Cross-sectional study

  7. RMD Open

    Novel vascular damage markers in SLE: insights from carotid colour Doppler ultrasound and aortic oscillometry in the LUPCARD cohort

    Cross-sectional study

  8. Osteoporos Int

    Radiofrequency Echographic Multi Spectrometry (REMS) for the evaluation of bone health in systemic lupus erythematosus (SLE)

    Diagnostic or prognostic study

  9. Lupus

    Exploring the association between preeclampsia and antiphospholipid antibodies. A prospective study

    Cohort study

  10. Lupus

    Current and future interventions for neonatal lupus: A review of the national library of Medicine’s clinical trials database

    Meta-analysis

  11. Lupus Sci Med

    Systemic lupus erythematosus comorbid with chronic spontaneous urticaria: a multicentre retrospective study

    Case-control study

  12. Lupus Sci Med

    Validation of proposals for definitions of moderate and severe disease activity in SLE: impact on flares, quality of life, damage accrual, hospitalisations and mortality

    Cohort study

  13. RMD Open

    Intraindividual cognitive function course over time in patients with systemic lupus erythematosus

    Cohort study

  14. Lupus Sci Med

    Combining mepacrine with hydroxychloroquine-based therapy in active systemic lupus erythematosus: an observational study of 106 patients from the Lupus-Cruces cohort

    Cohort study

  15. Lupus

    Evaluating the effectiveness of educational initiatives on recruiting underrepresented participants into SLE clinical trials

    Research article

  16. Arthritis Rheumatol

    Prognostic Value of Lupus Anticoagulant and Anti–β2 Glycoprotein I Antibody in Adverse Pregnancy Outcomes

    Cohort study

  17. Lupus

    Delayed onset of systemic lupus erythematosus in patients with idiopathic membranous nephropathy

    Cohort study

  18. Arthritis Rheumatol

    Mesenchymal Stromal Cell Therapy Alleviates Lupus Nephritis Through Inhibiting Caspase‐4/5/11–Mediated Noncanonical Pyroptosis in Macrophages

    Mechanistic study

  19. Lupus

    Validating the factor structure of the superwoman schema instrument in a cohort of black women with SLE

    Diagnostic or prognostic study

  20. Lupus

    Salivary proteomics profiling in cutaneous lupus erythematosus

    Cross-sectional study

  21. Lupus Sci Med

    Burden of herpes zoster among patients with systemic lupus erythematosus in the USA

    Cohort study

  22. Lupus Sci Med

    Function of follicular helper 17 T cells in driving B cells for anti-DNA autoantibody production in patients with SLE

    Mechanistic study

  23. Arthritis Rheumatol

    Glucagon‐Like Peptide‐1 Receptor Agonist Use and the Risk of Adverse Cardiac and Kidney Outcomes Among Patients With Systemic Lupus Erythematosus and Lupus Nephritis

    Cohort study

  24. Rheumatology (Oxford)

    Real-world experience of anifrolumab in 30 patients with refractory DM: a multicentre–multidisciplinary retrospective study

    Cohort study

  25. Lupus

    Risk factors for cytomegalovirus reactivation and disease in patients with systemic lupus erythematosus

    Cohort study

  26. Semin Arthritis Rheum

    Metabolomics in systemic lupus erythematosus: A systematic review and meta-analysis

    Meta-analysis

  27. J Rheumatol

    The Effect of Everyday Discrimination on Systemic Lupus Erythematosus Disease Activity and Mental Health Outcomes

    Cross-sectional study

  28. Clin Exp Rheumatol

    Lupus nephritis outcomes when kidney biopsy is not feasible: findings from a tertiary centre inception cohort

    Cohort study

  29. Rheumatology (Oxford)

    Diffuse alveolar haemorrhage in antiphospholipid syndrome: a French series of 26 patients

    Cohort study

  30. Rheumatology (Oxford)

    Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndrome

    Cohort study

  31. Ann Rheum Dis

    Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality

    Cohort study

  32. Rheumatology (Oxford)

    Predictors and long-term impact of sustained complete renal response in lupus nephritis patients over a median 10-year follow-up

    Cohort study

  33. Rheumatology (Oxford)

    Prevalence, clinical associations and outcomes of pericarditis in systemic lupus erythematosus: insights from the University of Toronto Lupus Clinic

    Cohort study

  34. Arthritis Rheumatol

    A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus

    Randomized controlled trial

  35. Rheumatology (Oxford)

    Early antiproteinuric effect of voclosporin in patients with LN in a real-life setting: preliminary results from the VoRLiSS ( Vo closporin in R eal L ife S etting S tudy) experience

    Cohort study

  36. Rheumatology (Oxford)

    Immunosuppressant use and adverse pregnancy outcomes in women with systemic lupus erythematosus: a retrospective cohort study in Korea

    Cohort study

  37. Rheumatology (Oxford)

    International development and validation of a multilingual bank of items for the self-assessment of essential knowledge by systemic lupus erythematosus patients: the SLE Knowledge Assessment score (SLAKE)

    Diagnostic or prognostic study

  38. Rheumatology (Oxford)

    Patient–physician discordance in assessing SLE disease activity: longitudinal analysis of disease-related variables and quality of life

    Cohort study

  39. Lupus Sci Med

    Risk factors and outcomes of posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a retrospective-multicentre cohort study and systematic literature review

    Cohort study

  40. Scand J Rheumatol

    Sensitive detection of plasma interferon regulatory factor-5 (IRF5) by solid-phase proximity ligation assay validates IRF5 high and low subgroups in patients with systemic lupus erythematosus

    Diagnostic or prognostic study

All 1,848 Briefs in ExploreShowing Briefs 441–480 of 1,848, newest first